Ischemia Global Clinical Trials Review, H1, 2012

• Publication date: June 2012
• Report size: 120 pages

Ischemia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction acro...

Ischemia Global Clinical Trials Review, H1, 2012



Summary



GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Ischemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Ischemia 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Ischemia Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Merck & Co., Inc. 35
Clinical Trial Overview of Merck & Co., Inc. 35
TCA Cellular Therapy, LLC 36
Clinical Trial Overview of TCA Cellular Therapy, LLC 36
ViroMed Co., Ltd. 37
Clinical Trial Overview of ViroMed Co., Ltd. 37
Sangart, Inc. 38
Clinical Trial Overview of Sangart, Inc. 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
AnGes MG, Inc. 40
Clinical Trial Overview of AnGes MG, Inc. 40
Pluristem Therapeutics Inc. 41
Clinical Trial Overview of Pluristem Therapeutics Inc. 41
Medistem, Inc. 42
Clinical Trial Overview of Medistem, Inc. 42
Stempeutics Research Private Limited 43
Clinical Trial Overview of Stempeutics Research Private Limited 43
St Vincent's Hospital Melbourne Pty Ltd 44
Clinical Trial Overview of St Vincent's Hospital Melbourne Pty Ltd 44
Johnson & Johnson 45
Clinical Trial Overview of Johnson & Johnson 45
Aastrom Biosciences, Inc. 46
Clinical Trial Overview of Aastrom Biosciences, Inc. 46
Abbott Laboratories 47
Clinical Trial Overview of Abbott Laboratories 47
medac GmbH 48
Clinical Trial Overview of medac GmbH 48
Gilead Sciences, Inc. 49
Clinical Trial Overview of Gilead Sciences, Inc. 49
Lantheus Medical Imaging, Inc. 50
Clinical Trial Overview of Lantheus Medical Imaging, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Scios Inc. 52
Clinical Trial Overview of Scios Inc. 52
Medicure Inc. 53
Clinical Trial Overview of Medicure Inc. 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Radboud University 54
Clinical Trial Overview of Radboud University 54
Medical University of Vienna 55
Clinical Trial Overview of Medical University of Vienna 55
The University of Edinburgh 56
Clinical Trial Overview of The University of Edinburgh 56
Northwestern University 57
Clinical Trial Overview of Northwestern University 57
Seoul National University Hospital 58
Clinical Trial Overview of Seoul National University Hospital 58
University Hospital Freiburg 59
Clinical Trial Overview of University Hospital Freiburg 59
Rigshospitalet 60
Clinical Trial Overview of Rigshospitalet 60
Kyoto University 61
Clinical Trial Overview of Kyoto University 61
Xijing Hospital 62
Clinical Trial Overview of Xijing Hospital 62
Charite- Universitatsmedizin Berlin 63
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 63
Kyushu University 64
Clinical Trial Overview of Kyushu University 64
Academic Medical Centre 65
Clinical Trial Overview of Academic Medical Centre 65
Clinical Trial Overview of 66
Johann Wolfgang Goethe University Hospitals 66
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 66
Maastricht University Medical Center 67
Clinical Trial Overview of Maastricht University Medical Center 67
Assistance Publique - Hopitaux de Paris 68
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 68
University of Florida 69
Clinical Trial Overview of University of Florida 69
Laval University 70
Clinical Trial Overview of Laval University 70
Leiden University Medical Center 71
Clinical Trial Overview of Leiden University Medical Center 71
UMC Utrecht 72
Clinical Trial Overview of UMC Utrecht 72
Five Key Clinical Profiles 73
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120

List of Tables

Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Ischemia Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Ischemia Therapeutics Clinical Trials, G7 Countries, 2012* 17
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Ischemia Therapeutics Clinical Trials, E7 Countries, 2012* 19
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Ischemia Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Ischemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 34
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 35
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2012* 36
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2012* 37
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2012* 38
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 39
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2012* 40
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2012* 41
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2012* 42
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2012* 43
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Melbourne Pty Ltd, 2012* 44
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 45
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2012* 46
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 47
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2012* 48
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 49
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lantheus Medical Imaging, Inc., 2012* 50
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 51
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2012* 52
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2012* 53
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 54
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 55
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012* 56
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 57
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 58
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012* 59
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012* 60
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 61
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2012* 62
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 63
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012* 64
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 65
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012* 66
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012* 67
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 68
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 69
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2012* 70
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012* 71
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012* 72

List of Figures

Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
GlobalData Methodology 118